262 results
Page 2 of 14
8-K
EX-99.1
4cr3r p4wlvn7fxgq1
13 Sep 22
Alnylam Announces Proposed Offering of $900 Million Convertible Senior Notes
4:05pm
8-K
EX-99.1
0cznc3s5l3uitv1f
28 Jul 22
Results of Operations and Financial Condition
8:10am
8-K
EX-99.1
qnzq5yoedwlp5el8gd
14 Jun 22
Other Events
7:30am
8-K
EX-99.1
i5esm9ap
28 Apr 22
Results of Operations and Financial Condition
8:10am
8-K
EX-99.1
w2cdzdej3p
5 Apr 22
Alnylam Announces Retirement of Steven Paul, M.D. from Board of Directors
4:16pm
8-K
EX-99.1
4xaz qgqf7e
4 Apr 22
Alnylam Announces 3-Month Extension of Review Period for New Drug Application for Vutrisiran
7:35am
8-K
EX-99.1
3wdo8o4d9jlcs ohk2j
10 Feb 22
Results of Operations and Financial Condition
8:10am
8-K
EX-99.1
t9y5pm 40rclrj
10 Jan 22
Alnylam Announces Preliminary* Fourth Quarter and Full Year 2021 Global Net Product Revenues and Provides Additional Updates
7:01am
8-K
EX-99.1
8ue8a69itls86zfaqvz1
4 Jan 22
Alnylam Announces Promotion of Dr. Akshay Vaishnaw to President
4:16pm
8-K
kz0c gbe9
28 Oct 21
Alnylam Pharmaceuticals Reports Third Quarter 2021 Financial Results and Highlights Recent Period Activity
8:11am
8-K
EX-99.1
ekn85
28 Oct 21
Alnylam Pharmaceuticals Reports Third Quarter 2021 Financial Results and Highlights Recent Period Activity
8:11am
8-K
EX-99.2
8qb83jemz59q4iv
28 Oct 21
Alnylam Pharmaceuticals Reports Third Quarter 2021 Financial Results and Highlights Recent Period Activity
8:11am
8-K
apc6f5pxq3e
3 Aug 21
Alnylam Pharmaceuticals Reports Second Quarter 2021 Financial Results and Highlights
8:10am
8-K
EX-99.1
1acv1jt69bwny
3 Aug 21
Alnylam Pharmaceuticals Reports Second Quarter 2021 Financial Results and Highlights
8:10am